Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Clinical efficacy and safety of daratumumab-carfilzomib based therapy in newly diagnosed multiple myeloma: A retrospective cohort analysis

Chengping Li, Liyin Li, Deyun Li, Li Luo, Xiaodan Wang, Yao Zhou, Song Yan, Man Xu, Kunyang Qian

Blood (2025) 146 (Supplement 1): 7579.

https://doi.org/10.1182/blood-2025-7579

Published: 2025

Journal Articles

HMGA1 chromatin regulator induces inflammatory signals and promotes atherogenesis in Tet2 mutant clonal hematopoiesis

Zanshe Thompson, Iliana Herrera, Zion Williams, Li Luo, Audrey-Ann Supreme, Bailey West, Hyun-sung Woo, Alexander Bick, Marios Arvanitis, Charles Lowenstein, Lewis Becker, Linda Resar

Blood (2025) 146 (Supplement 1): 3177.

https://doi.org/10.1182/blood-2025-3177

Published: 2025

Journal Articles

HMGA1 chromatin regulators drive transcriptional networks governing cell cycle progression, immune escape, and menin-inhibitor resistance in KMT2A-r Acute Myeloid Leukemia

Bailey West, Li Luo, Zanshe Thompson, Yuze Du, Leslie Cope, Joseph Kim, Audrey-Ann Supreme, Faiza Shaik, Isha Maloo, Kathryn Mi, Alison Park, Soheil Meshinchi, Rhonda Ries, Jung-Hyun Kim, Linda Resar

Blood (2025) 146 (Supplement 1): 5027.

https://doi.org/10.1182/blood-2025-5027

Published: 2025

Journal Articles

HMGA1 chromatin regulators drive transcriptional networks involved in megakaryocyte expansion, fibrosis, and sensitivity to interferon signaling in JAK2-V617F MPN

Linda Resar, Zanshe Thompson, Li Luo, Bailey West, Leslie Cope, Lih-Ling Lin, Erik Sampson, Jerry Spivak

Blood (2025) 146 (Supplement 1): 7285.

https://doi.org/10.1182/blood-2025-7285

Published: 2025

Journal Articles

HMGA1-ETV5 Axis Is Essential for Relapsed B-Cell Leukemia and Provides Novel Therapeutic Targets

Jung-Hyun Kim, Liping Li, Zixin Zhang, Katharina Hayer, Li Luo, Leslie Cope, Lingling Xian, Andrei Thomas-Tikhonenko, Linda Resar

Blood (2022) 140 (Supplement 1): 3478–3479.

https://doi.org/10.1182/blood-2022-167037

Published: 2022

Journal Articles

High Mobility Group A1 (HMGA1) Epigenetic Regulators Induce ETV5 Networks in Relapsed B-Cell Leukemia and Provide Novel Therapeutic Targets

Jung-Hyun Kim, Liping Li, Zixin Zhang, Katharina Hayer, Lingling Xian, Li Luo, Leslie Cope, Andrei Thomas-Tikhonenko, Linda Resar

Blood (2021) 138 (Supplement 1): 707.

https://doi.org/10.1182/blood-2021-152950

Published: 2021

Journal Articles

HMGA1 Chromatin Regulators Drive Progression in Myeloproliferative Neoplasms through Epigenetic Rewiring to Induce Networks Involved in GATA2 and Proliferation

Liping Li, Jung-Hyun Kim, Wenyan Lu, Leslie Cope, Donna M Williams, Joseph Kim, Raajit Rampal, Richard Koche, Lingling Xian, Li Luo, Marija Vasiljevic, Daniel R Matson, Zhizhuang Joe Zhao, Ophelia Rogers, Matthew C. Stubbs, Karen Reddy, Jerry L. Spivak, Alison R. Moliterno, Linda Resar

Blood (2021) 138 (Supplement 1): 625.

https://doi.org/10.1182/blood-2021-144712

Published: 2021

Journal Articles

High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALL

Liping Li, MD PhD, Katharina Hayer, Lingling Xian, MD PhD, Li Luo, PhD, Leslie Cope, Andrei Thomas-Tikhonenko, PhD, Linda Resar, MD

Blood (2019) 134 (Supplement_1): 3946.

https://doi.org/10.1182/blood-2019-130261

Published: 2019

Journal Articles

The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine Models

Alison R. Moliterno, MD, Donna Marie Williams, PhD, Liping Li, MD PhD, Lingling Xian, MD PhD, Li Luo, PhD, Amy S. Duffield, MD PhD, Ophelia Rogers, Jerry L. Spivak, MD, Linda Resar, MD

Blood (2019) 134 (Supplement_1): 472.

https://doi.org/10.1182/blood-2019-131432

Published: 2019

Journal Articles

High Mobility Group A1 Chromatin Remodeling Proteins Amplify Inflammatory Networks to Drive Leukemic Transformation in Chronic Myeloproliferative Neoplasia in Humans and JAK2 V617F Transgenic Mouse Models

Linda Resar, MD, Donna Marie Williams, PhD, Lingling Xian, MD PhD, Wenyan Lu, PhD, Briyana Chisholm, BS, Li Luo, PhD, Zhizhuang Joe Zhao, PhD, Ophelia Rogers, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2018) 132 (Supplement 1): 102.

https://doi.org/10.1182/blood-2018-99-119549

Published: 2018

Journal Articles

Drugging DNA Repair to Target T-ALL Cells

Yashodhara Dasgupta, Konstantin Golovine, Margaret Nieborowska-Skorska, Li Luo, Ksenia Matlawska-Wasowska, Charles G. Mullighan, MBBS, MD, Tomasz Skorski

Blood (2017) 130 (Supplement 1): 2610.

https://doi.org/10.1182/blood.V130.Suppl_1.2610.2610

Published: 2017

Journal Articles

Nonoverlapping functions for Notch1 and Notch3 during murine steady-state thymic lymphopoiesis

Jianjun Shi, Mohammad Fallahi, Jun-Li Luo, Howard T. Petrie

Blood (2011) 118 (9): 2511–2519.

https://doi.org/10.1182/blood-2011-04-346726

Published: 2011

Journal Articles

Anti-CD45–mediated cytoreduction to facilitate allogeneic stem cell transplantation

Gerald G. Wulf, Kang-Li Luo, Margaret A. Goodell, Malcolm K. Brenner

Blood (2003) 101 (6): 2434–2439.

https://doi.org/10.1182/blood-2002-08-2379

Published: 2003

Journal Articles

A missense mutation in the heavy subunit of γ-glutamylcysteine synthetase gene causes hemolytic anemia

Ellinor Ristoff, Camilla Augustson, Judy Geissler, Thea de Rijk, Katarina Carlsson, Jia-Li Luo, Kerstin Andersson, Ron S. Weening, Rob van Zwieten, Agne Larsson, Dirk Roos

Blood (2000) 95 (7): 2193–2196.

https://doi.org/10.1182/blood.V95.7.2193

Published: 2000

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Clinical efficacy and safety of daratumumab-carfilzomib based therapy in newly diagnosed multiple myeloma: A retrospective cohort analysis

HMGA1 chromatin regulator induces inflammatory signals and promotes atherogenesis in Tet2 mutant clonal hematopoiesis

HMGA1 chromatin regulators drive transcriptional networks governing cell cycle progression, immune escape, and menin-inhibitor resistance in KMT2A-r Acute Myeloid Leukemia

HMGA1 chromatin regulators drive transcriptional networks involved in megakaryocyte expansion, fibrosis, and sensitivity to interferon signaling in JAK2-V617F MPN

HMGA1-ETV5 Axis Is Essential for Relapsed B-Cell Leukemia and Provides Novel Therapeutic Targets

High Mobility Group A1 (HMGA1) Epigenetic Regulators Induce ETV5 Networks in Relapsed B-Cell Leukemia and Provide Novel Therapeutic Targets

HMGA1 Chromatin Regulators Drive Progression in Myeloproliferative Neoplasms through Epigenetic Rewiring to Induce Networks Involved in GATA2 and Proliferation

High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALL

The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine Models

High Mobility Group A1 Chromatin Remodeling Proteins Amplify Inflammatory Networks to Drive Leukemic Transformation in Chronic Myeloproliferative Neoplasia in Humans and JAK2 V617F Transgenic Mouse Models

Drugging DNA Repair to Target T-ALL Cells

Nonoverlapping functions for Notch1 and Notch3 during murine steady-state thymic lymphopoiesis

Anti-CD45–mediated cytoreduction to facilitate allogeneic stem cell transplantation

A missense mutation in the heavy subunit of γ-glutamylcysteine synthetase gene causes hemolytic anemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only